1 HDIVC Information for Patients and Physicians

Intravenously administered high dose ascorbic acid (HDIVC) as used in cases of patients who have cancer has considerable mythology surrounding it. The purpose of this review is not to exhaustively recap the data regarding this therapy but rather to address basicissues of safety, pharmacology and outcomes of ongoing research.

Share:

Share on facebook
Share on twitter
Share on linkedin
Share on email

More IV Monographs

Scroll to Top